Head to head
Bench Grade Peptides vs NeuroLabs Research
Bench Grade Peptides scores 80.7 of 100 against NeuroLabs Research at 79, a gap narrow enough that either is defensible. Bench Grade Peptides publishes more certificates: 53 against 14.
Same rubric, same date · 67 certificates between them · 28 compounds in common
 80.7/100 Rank 10 of 57 |  79/100 Rank 12 of 57 | |
|---|---|---|
| Score0–100 on the published rubric | 80.7 Well documented | 79 Well documented |
| Evidence coverageShare of scored fields sourced | 89% | 91% |
| Certificates on fileLot records this index read | 53 | 14 |
| Testing laboratory | AV Analytics | Kovera Labs |
| ISO/IEC 17025 | — | — |
| Label accuracyMean gap, labeled vs assayed | 6.8% | 10.6% |
| Basket price% of the peer median | 100% | 109% |
| Enforcement recordActions on record | None on record | None on record |
| Discount code | — | — |
Price, compound by compound
Price per milligram at each vendor’s own listed vial size. Bench Grade Peptides is cheaper on 16, NeuroLabs Research on 12. The median column is the peer median across every vendor this index prices.
| Compound | Bench Grade Peptides | NeuroLabs Research | Median |
|---|---|---|---|
| 5-Amino-1MQ | $8.00 | $7.19 | $3.30 |
| AOD-9604 | $21 | $12 | $11 |
| ARA-290 | $5.00 | $9.79 | $5.50 |
| BPC-157 | $3.90 | $6.00 | $5.50 |
| Cagrilintide | $13 | $16 | $9.90 |
| CJC-1295 | $9.00 | $12 | $8.98 |
| Dihexa | $5.70 | $7.50 | $6.75 |
| DSIP | $8.60 | $8.39 | $7.00 |
| Epithalon | $4.20 | $5.40 | $4.10 |
| GHK-Cu | $0.38 | $0.45 | $0.60 |
| Glutathione | $0.05 | $0.04 | $0.05 |
| IGF-1 LR3 | $139 | $102 | $75 |
| Ipamorelin | $3.90 | $6.50 | $6.20 |
| Kisspeptin | $9.70 | $5.03 | $5.20 |
| KPV | $4.80 | $5.99 | $5.00 |
| Melanotan I | $4.60 | $4.19 | $4.19 |
| Melanotan II | $4.50 | $4.19 | $4.00 |
| MOTS-c | $4.70 | $4.50 | $5.50 |
| NAD+ | $0.12 | $0.15 | $0.12 |
| Pinealon | $4.40 | $5.99 | $4.70 |
| PT-141 | $4.60 | $7.19 | $4.50 |
| Retatrutide | $3.90 | $7.00 | $7.40 |
| Selank | $3.60 | $4.20 | $4.35 |
| Semax | $5.40 | $3.50 | $4.00 |
| SS-31 | $8.00 | $5.40 | $5.40 |
| TB-500 | $4.10 | $4.79 | $6.00 |
| Tesamorelin | $12 | $9.50 | $8.00 |
| Tirzepatide | $4.50 | $7.00 | $6.75 |
Which to pick
Pick Bench Grade Peptides if
you want the stronger documentation record of the two; you want the deeper certificate history (53 lots); you want the cheaper basket overall; you buy mostly the compounds it prices lower.
Pick NeuroLabs Research if
you prefer its catalogue or its terms; on the recorded evidence the two are close.
Questions
- Is Bench Grade Peptides or NeuroLabs Research better?
- Bench Grade Peptides scores 80.7 of 100 against NeuroLabs Research at 79, a gap narrow enough that either is defensible. Bench Grade Peptides publishes more certificates: 53 against 14. Both figures come from the same published rubric over sourced data points, and each links to the document behind it.
- Which of Bench Grade Peptides and NeuroLabs Research is cheaper?
- Across the 28 compounds both price, Bench Grade Peptides is cheaper on 16 and NeuroLabs Research on 12. Price per milligram is compared at each vendor's own listed vial size.
- Who tests Bench Grade Peptides and NeuroLabs Research peptides?
- Bench Grade Peptides: AV Analytics. NeuroLabs Research: Kovera Labs. A vendor-published certificate is recorded as a claim; only an independently commissioned assay counts as corroboration.
- How many certificates do Bench Grade Peptides and NeuroLabs Research publish?
- Bench Grade Peptides has 53 lot-level certificates on file and NeuroLabs Research has 14. Both counts are of certificates this index located and read, not of certificates claimed.
Both records were last re-verified on 2026-09-28 and 2026-09-30. Every figure is computed from the same rubric over sourced data points; see the methodology or the full best peptide vendors ranking. Partner links are marked and cannot affect a score.